Authors

Natalia Vieito-Pérez1, Gemma María Marquina-Díaz2, Paula Méndez-Brea3, Carmen Vidal-Pan4,Francisco Gude-Sampedro5, Diego Gabriel Mosteiro-Miguéns6

Position

1Especialista en Enfermería Pediátrica. Complejo Hospitalario Universitario de Santiago de Compostela. A Coruña (España)2Diplomada en Enfermería. Complejo Hospitalario Universitario de Santiago de Compostela. A Coruña (España)3Licenciada en Medicina. Servicio de Alergología del Complejo Hospitalario Universitario de Santiago de Compostela. A Coruña (España)4Doctora en Medicina. Servicio de Alergología del Complejo Hospitalario Universitario de Santiago de Compostela. A Coruña (España)5Doctor en Medicina. Unidad de Epidemiología Clínica. Complejo Hospitalario Universitario de Santiago de Compostela. A Coruña (España)6Especialista en Enfermería Familiar y Comunitaria. Centro de Salud Concepción Arenal. A Coruña (España)

Contact address

Natalia Vieito Pérez. Complejo Hospitalario Universitario de Santiago de Compostela. C/ da Choupana, s/n. 15706 Santiago de Compostela, A Coruña (Espa

Contact email: natalia.vieto.perez@sergas.es

Abstract

Objective: to determine the level of trust in the diagnosis excluding allergy in patients with suspected hypersensitivity to betalactam antibiotics and/or NSAIDs. Additionally, it was intended to describe the attitude of patients towards taking in the future the drug which motivated the study.
Method: a descriptive cross-sectional study was conducted; 103 >18-year old patients were selected, of both genders and with a negative result in diagnostic tests for betalactam drugs and/or NSAIDs. Participants were evaluated through a heteroadministered questionnaire at their usual Allergology clinical practice.
Results: the level of trust towards the previous allergy label was moderate for betalactam antibiotics (6.4/10) and for NSAIDs (6.1/10), high towards the negative diagnosis for allergy (betalactam drugs: 7.5/10; NSAIDs: 7.9/10), and moderate regarding taking in the future the drug under study, after a negative diagnosis for allergy (betalactam drugs: 6.7/10; NSAIDs: 6.3/10). The degree of trust towards the diagnosis excluding allergy to betalactam drugs or NSAIDs increased regarding the previous degree for suspected allergy, in both drugs (p= 0.01).
Conclusions: there is a high degree of trust in patients regarding their diagnosis excluding allergy to betalactam drugs and/or NSAIDs. However, trust regarding taking in the future the drug which motivated the study, after a negative diagnosis of allergy, was reduced to moderate. Health professionals must provide effective health education that solves uncertainties in terms of conducting the test and reinforces trust by patients for taking the drug in the future.

Keywords:

Aanti-inflammatory agents; non-steroidal; attitude to health; beta-lactams; drug hypersensitivity; trust

Versión en Español

Título:

Confianza y actitud tras un diagnóstico negativo de alergia a fármacos betalactámicos y/o AINE